Text Size
224 studies found for:    nicotinamide

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
Conditions: Chronic Renal Failure;   Hemodialysis
Interventions: Drug: nicotinamide;   Drug: sevelamer;   Drug: cinacalcet
2 Completed Biosynthesis of PGD2 in Vivo
Condition: Healthy Volunteer
Interventions: Dietary Supplement: 5 days of placebo followed by 600mg niacin;   Dietary Supplement: aspirin first;   Drug: 81 mg Aspirin;   Dietary Supplement: Niaspan;   Drug: Celebrex and niacin
3 Unknown † Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)
Condition: Elevated Lipoprotein(a) Levels
Interventions: Drug: Nicotinic acid (niacin);   Drug: Placebo
4 Completed Effect of Niacin in the Lipoprotein (a) Concentration
Condition: Hypercholesterolemia
Intervention: Drug: Niacin/Laropiprant
5 Completed
Has Results 		A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Comparator: ER niacin (+) laropiprant;   Drug: Comparator: ER niacin;   Drug: Comparator: laropiprant;   Drug: Comparator: placebo
6 Completed
Has Results 		A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)
Condition: Hypercholesterolemia
Interventions: Drug: Comparator: niacin + laropiprant;   Drug: Comparator: niacin;   Drug: Comparator: laropiprant;   Drug: Comparator: placebo
7 Completed SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia
Condition: Dyslipidemia
Intervention: Drug: Slo-Niacin, atorvastatin
8 Completed Niacin/Laropiprant and Endothelial Function
Condition: Coronary Heart Disease
Interventions: Drug: Niacin/laropiprant;   Drug: Placebo
9 Completed Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis
Condition: Healthy Volunteers
Interventions: Drug: Niacin;   Other: Placebo
10 Completed Nicotinamide in the Treatment of Psoriasis
Condition: Psoriasis
Interventions: Drug: Calcipotriol plus Nicotinamide;   Drug: Calcipotriol
11 Active, not recruiting Safety Study of Nicotinamide to Treat Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Nicotinamide;   Drug: Enduramide placebo
12 Completed
Has Results 		To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)
Condition: Hypercholesterolemia
Interventions: Drug: Comparator: ezetimibe/simvastatin + niacin (ER);   Drug: Comparator: Placebo to ezetimibe/simvastatin;   Drug: Comparator: niacin (ER) tablet;   Drug: Comparator: ezetimibe (+) simvastatin;   Drug: Comparator: Placebo to Niacin (ER);   Drug: Comparator: ezetimibe/simvastatin and niacin (ER);   Drug: Comparator: ezetimibe and simvastatin;   Drug: Comparator: Placebo to niacin (ER)
13 Terminated ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
Conditions: HIV;   Atherosclerosis
Interventions: Drug: niacin/laropiprant;   Drug: Placebo
14 Completed Role of Prostaglandins on Niacin-Induced Flushing
Condition: Flushing
Intervention: Drug: Niacin and aspirin
15 Terminated A Study to Evaluate Efficacy and Safety of Extended-Release Niacin (+) Laropiprant (+) Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)
Conditions: Primary Hypercholesterolemia;   Dyslipidemia
Interventions: Drug: ER niacin/laropiprant/simvastatin;   Drug: ER niacin/laropiprant;   Drug: Simvastatin;   Drug: Placebo to match simvastatin
16 Completed The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
Condition: Hyperphosphatemia
Interventions: Drug: Niacinamide;   Drug: Placebo
17 Completed Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
Conditions: Chronic Kidney Disease;   Hemodialysis;   Hyperphosphatemia
Intervention: Drug: Nicotinamide
18 Active, not recruiting Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions
Conditions: Central Retinal Vein Occlusion;   Branch Retinal Vein Occlusion
Intervention: Drug: nicotinic acid
19 Completed Plaque Inflammation and Dysfunctional HDL Cholesterol in Participants Receiving Niacin and Statins in the AIM-HIGH Study (The HDL Proteomics Study)
Conditions: Cardiovascular Diseases;   Heart Diseases;   Coronary Disease;   Atherosclerosis;   Myocardial Infarction
Intervention: Drug: Simvastatin, simvastatin plus extended-release niacin
20 Completed A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers
Conditions: Healthy Subjects;   Dyslipidaemias
Intervention: Drug: GSK256073A tablets + IR niacin tablets
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years